SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001140361-21-017445
Filing Date
2021-05-14
Accepted
2021-05-14 16:56:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D brhc10024561_sc13d.htm SC 13D 63167
2 EXHIBIT 1 brhc10024561_ex1.htm EX-99.1 8866
  Complete submission text file 0001140361-21-017445.txt   73273
Mailing Address C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Hecht Peter M (Filed by) CIK: 0001478485 (see all company filings)

Type: SC 13D

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90979 | Film No.: 21925632
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences